Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  HIV Infection

  Free Subscription


Articles published in PLoS Med

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    November 2022

  1. Correction: HIV prevention for the next decade: Appropriate, person-centred, prioritised, effective, combination prevention.
    PLoS Med. 2022;19:e1004131.
    PubMed     Abstract available


    October 2022
  2. HENSLEY KS, Jongkees MJ, Geers D, GeurtsvanKessel CH, et al
    Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
    PLoS Med. 2022;19:e1003979.
    PubMed     Abstract available


    September 2022
  3. GODFREY-FAUSSETT P, Frescura L, Abdool-Karim Q, Clayton M, et al
    HIV prevention for the next decade: Appropriate, person-centred, prioritised, effective, combination prevention.
    PLoS Med. 2022;19:e1004102.
    PubMed     Abstract available


  4. TAPSOBA JD, Cover J, Obong'o C, Brady M, et al
    Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
    PLoS Med. 2022;19:e1004097.
    PubMed     Abstract available


  5. PONS-DURAN C, Mombo-Ngoma G, Macete E, Desai M, et al
    Burden of malaria in pregnancy among adolescent girls compared to adult women in 5 sub-Saharan African countries: A secondary individual participant data meta-analysis of 2 clinical trials.
    PLoS Med. 2022;19:e1004084.
    PubMed     Abstract available


  6. EDMONDS A, Brazier E, Musick BS, Yotebieng M, et al
    Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study.
    PLoS Med. 2022;19:e1004089.
    PubMed     Abstract available


    August 2022
  7. VOJNOV L, Carmona S, Zeh C, Markby J, et al
    The performance of using dried blood spot specimens for HIV-1 viral load testing: A systematic review and meta-analysis.
    PLoS Med. 2022;19:e1004076.
    PubMed     Abstract available


  8. WANG C, Ong JJ, Zhao P, Weideman AM, et al
    Correction: Expanding syphilis test uptake using rapid dual self-testing for syphilis and HIV among men who have sex with men in China: A multiarm randomized controlled trial.
    PLoS Med. 2022;19:e1004071.
    PubMed     Abstract available


    June 2022
  9. NSENGIYUMVA NP, Campbell JR, Oxlade O, Vesga JF, et al
    Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
    PLoS Med. 2022;19:e1004032.
    PubMed     Abstract available


  10. TAKUVA S, Takalani A, Seocharan I, Yende-Zuma N, et al
    Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.
    PLoS Med. 2022;19:e1004024.
    PubMed     Abstract available


    May 2022
  11. MARTIN CA, Pan D, Melbourne C, Teece L, et al
    Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis.
    PLoS Med. 2022;19:e1004015.
    PubMed     Abstract available


    April 2022
  12. SUDFELD CR, Manji KP, Muhihi A, Duggan CP, et al
    Vitamin D3 supplementation during pregnancy and lactation for women living with HIV in Tanzania: A randomized controlled trial.
    PLoS Med. 2022;19:e1003973.
    PubMed     Abstract available


    March 2022
  13. LE TOURNEAU N, German A, Thompson R, Ford N, et al
    Evaluation of HIV treatment outcomes with reduced frequency of clinical encounters and antiretroviral treatment refills: A systematic review and meta-analysis.
    PLoS Med. 2022;19:e1003959.
    PubMed     Abstract available


  14. WANG C, Ong JJ, Zhao P, Weideman AM, et al
    Expanding syphilis test uptake using rapid dual self-testing for syphilis and HIV among men who have sex with men in China: A multiarm randomized controlled trial.
    PLoS Med. 2022;19:e1003930.
    PubMed     Abstract available


  15. MIRZAZADEH A, Eshun-Wilson I, Thompson RR, Bonyani A, et al
    Interventions to reengage people living with HIV who are lost to follow-up from HIV treatment programs: A systematic review and meta-analysis.
    PLoS Med. 2022;19:e1003940.
    PubMed     Abstract available


    February 2022
  16. LYONS C, Bendaud V, Bourey C, Erkkola T, et al
    Global assessment of existing HIV and key population stigma indicators: A data mapping exercise to inform country-level stigma measurement.
    PLoS Med. 2022;19:e1003914.
    PubMed     Abstract available


  17. ZHOU Y, Lu Y, Ni Y, Wu D, et al
    Monetary incentives and peer referral in promoting secondary distribution of HIV self-testing among men who have sex with men in China: A randomized controlled trial.
    PLoS Med. 2022;19:e1003928.
    PubMed     Abstract available


    January 2022
  18. FOO C, Shrestha P, Wang L, Du Q, et al
    Integrating tuberculosis and noncommunicable diseases care in low- and middle-income countries (LMICs): A systematic review.
    PLoS Med. 2022;19:e1003899.
    PubMed     Abstract available


  19. SIMMS V, Weiss HA, Chinoda S, Mutsinze A, et al
    Peer-led counselling with problem discussion therapy for adolescents living with HIV in Zimbabwe: A cluster-randomised trial.
    PLoS Med. 2022;19:e1003887.
    PubMed     Abstract available


  20. RODI P, Obermeyer W, Pablos-Mendez A, Gori A, et al
    Political rationale, aims, and outcomes of health-related high-level meetings and special sessions at the UN General Assembly: A policy research observational study.
    PLoS Med. 2022;19:e1003873.
    PubMed     Abstract available


  21. HODGINS C, Stannah J, Kuchukhidze S, Zembe L, et al
    Population sizes, HIV prevalence, and HIV prevention among men who paid for sex in sub-Saharan Africa (2000-2020): A meta-analysis of 87 population-based surveys.
    PLoS Med. 2022;19:e1003861.
    PubMed     Abstract available


    December 2021
  22. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Coyle P, et al
    Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
    PLoS Med. 2021;18:e1003879.
    PubMed     Abstract available


  23. SEMITALA FC, Kadota JL, Musinguzi A, Nabunje J, et al
    Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
    PLoS Med. 2021;18:e1003875.
    PubMed     Abstract available


  24. KARUNA S, Li SS, Grant S, Walsh SR, et al
    Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.
    PLoS Med. 2021;18:e1003868.
    PubMed     Abstract available


    November 2021
  25. STONER MCD, Kilburn K, Godfrey-Faussett P, Ghys P, et al
    Cash transfers for HIV prevention: A systematic review.
    PLoS Med. 2021;18:e1003866.
    PubMed     Abstract available


  26. NDLOVU Z, Ellman T
    Lay testing cadres and point-of-care diagnostic tests for HIV and other diseases: An essential combination in health service delivery.
    PLoS Med. 2021;18:e1003867.
    PubMed     Abstract available


  27. MARTIN CA, Marshall C, Patel P, Goss C, et al
    SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
    PLoS Med. 2021;18:e1003823.
    PubMed     Abstract available


  28. BULSTRA CA, Hontelez JAC, Otto M, Stepanova A, et al
    Integrating HIV services and other health services: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003836.
    PubMed     Abstract available


  29. HONTELEZ JAC, Bulstra CA, Yakusik A, Lamontagne E, et al
    Evidence-based policymaking when evidence is incomplete: The case of HIV programme integration.
    PLoS Med. 2021;18:e1003835.
    PubMed     Abstract available


    October 2021
  30. BIRDTHISTLE I, Kwaro D, Shahmanesh M, Baisley K, et al
    Evaluating the impact of DREAMS on HIV incidence among adolescent girls and young women: A population-based cohort study in Kenya and South Africa.
    PLoS Med. 2021;18:e1003837.
    PubMed     Abstract available


  31. AMSTUTZ A, Lejone TI, Khesa L, Kopo M, et al
    Offering ART refill through community health workers versus clinic-based follow-up after home-based same-day ART initiation in rural Lesotho: The VIBRA cluster-randomized clinical trial.
    PLoS Med. 2021;18:e1003839.
    PubMed     Abstract available


  32. STOVER J, Glaubius R, Teng Y, Kelly S, et al
    Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
    PLoS Med. 2021;18:e1003831.
    PubMed     Abstract available


  33. BARRY H, Mutua G, Kibuuka H, Anywaine Z, et al
    Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.
    PLoS Med. 2021;18:e1003813.
    PubMed     Abstract available


  34. GENG EH, Reid MJA, Goosby E, Abdool-Karim Q, et al
    COVID-19 and global equity for health: The good, the bad, and the wicked.
    PLoS Med. 2021;18:e1003797.
    PubMed     Abstract available


    September 2021
  35. NAGATA JM, Epstein A, Ganson KT, Benmarhnia T, et al
    Drought and child vaccination coverage in 22 countries in sub-Saharan Africa: A retrospective analysis of national survey data from 2011 to 2019.
    PLoS Med. 2021;18:e1003678.
    PubMed     Abstract available


  36. ZULAIKA G, Nyothach E, van Eijk AM, Obor D, et al
    Factors associated with the prevalence of HIV, HSV-2, pregnancy, and reported sexual activity among adolescent girls in rural western Kenya: A cross-sectional analysis of baseline data in a cluster randomized controlled trial.
    PLoS Med. 2021;18:e1003756.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: